/term/cash-receipts-from-securities-related-activities/FRA:978 Adagene (FRA:978) Cash Receipts from Securities Related Act
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adagene Inc (FRA:978) » Definitions » Cash Receipts from Securities Related Activities

Adagene (FRA:978) Cash Receipts from Securities Related Activities


View and export this data going back to 2021. Start your Free Trial

What is Adagene Cash Receipts from Securities Related Activities?

Cash Receipts from Securities Related Activities only applicable to companies reporting Cash Flow from Operations in direct method.

Adagene (FRA:978) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adagene Inc (FRA:978) » Definitions » Cash Receipts from Securities Related Activities
Comparable Companies
CRVS FIXX OCEA ASMB IOBT HCWB ANEB ALGS ANVS ACET OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
ADAG:USA
Address
Xinghu Street, Suzhou Industrial Park, 4th Floor, Building C14, No. 218, Jiangsu Province, Suzhou, CHN, 215123
Website
https://www.adagene.com
Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.